Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorder

计划入组 32 人 · 首次发布于 2011 年 6 月 23 日

Experience of Using Lipano in Children With Fatty Acid Oxidation Disorders

计划入组 5 人 · 首次发布于 2020 年 5 月 22 日

Exercise Intolerance Study in Long Chain Fatty Acid Oxidation Disorders

计划入组 50 人 · 首次发布于 2023 年 6 月 29 日

Triheptanoin(Dojolvi)

C₂₄H₄₄O₆

nucleoside short-chain fatty acid

FAO inhibitor (University of Colorado)

Chain Drug Consortium

United States

Chain Drug Marketing Association, Inc.

United States

THE PARKINSON'S AND MOVEMENT DISORDER INSTITUTE

United States

Ultragenyx Reports Positive Q3 2024 Results and Clinical Updates

Four-Gene Fatty Acid Metabolism Signature Distinguishes Diabetic Foot Ulcers With High Diagnostic Accuracy

Disruption of de novo fatty acid biosynthesis rewires cellular lipid metabolism toward mTOR signaling